Outcomes | Crude | Model A& | ||
---|---|---|---|---|
HR | 95 % CI | HR | 95 % CI | |
Urinary tract infection | Â | Â | Â | Â |
Fatigue | 1.21 | 1.16–1.27a | 1.06 | 1.01–1.12c |
Resistance | 1.30 | 1.12–1.51b | 0.998 | 0.86–1.16 |
Ambulation | 1.91 | 1.57–2.32a | 1.17 | 0.97–1.43 |
Illness | 1.81 | 1.74–1.88a | 1.22 | 1.15–1.29a |
Loss of weight | 1.83 | 1.60–2.09a | 1.02 | 0.89–1.16 |
Urinary tract infection with sepsis | Â | Â | Â | |
Fatigue | 1.21 | 1.11–1.33a | 1.35 | 0.95–1.14 |
Resistance | 1.49 | 1.15–1.94b | 1.03 | 0.79–1.34 |
Ambulation | 2.93 | 2.17–3.95a | 1.47 | 1.08–1.99c |
Illness | 2.43 | 2.25–2.63a | 1.07 | 0.96–1.20 |
Loss of weight | 2.82 | 2.29–3.46a | 1.04 | 0.84–1.28 |